CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	382K 335K 317K 289K 540K 36.63M 544K 3.79M 1.47M 18.71M 1.43M 1.4M 60.14M	P/E 2014	-2.3x	P/E 2015	-2.17x
Enterprise Value	539K 473K 446K 407K 762K 51.63M 767K 5.34M 2.07M 26.38M 2.02M 1.98M 84.77M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.49%	Yield 2014 *	-	Yield 2015	-

10/09/21	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
04/09/21	CardioGenics Holdings Inc. Announces License Agreement	CI
02/11/15	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI
05/10/15	CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	CI
13/01/15	CardioGenics Holdings Inc. Appoints Karim Murabet as Director	CI
27/09/13	CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	CI
21/08/13	CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	CI
05/06/13	CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	CI
03/06/13	CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	CI
31/05/13	CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	CI
01/03/13	CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	CI
27/02/13	CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	CI
17/04/12	CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	CI

29/09/21	UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
10/09/21	CARDIOGENICS : ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
04/09/21	CARDIOGENICS : ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION	AQ
05/11/15	CardioGenics : Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap	MW
06/10/15	CardioGenics : Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap	MW

Manager	Title	Age	Since
Yahia A. Gawad CEO	Chief Executive Officer	68	27/10/2009
James A. Essex DFI	Director of Finance/CFO	78	16/06/2010
Linda J. Sterling IRC	Investor Relations Contact	65	-

Director	Title	Age	Since
Yahia A. Gawad BRD	Director/Board Member	68	06/04/2011
Julian Neil Tabatznik CHM	Chairman	76	16/06/2010
Linda J. Sterling BRD	Director/Board Member	65	16/06/2010

CardioGenics Holdings Inc Stock Other OTC

Stocks

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Valuation: CardioGenics Holdings Inc

Latest news: CardioGenics Holdings Inc

Press Releases: CardioGenics Holdings Inc

Quotes and Performance

Managers and Directors: CardioGenics Holdings Inc

Diagnostic & Testing Substances

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOGENICS HOLDINGS INC	-35.19%	+110.24%	-	-	142
GUARDANT HEALTH, INC.	+0.45%	-1.19%	+194.53%	+574.98%	23.79B
10X GENOMICS, INC.	+1.90%	+11.89%	+617.24%	+107.98%	11.17B
BIOMÉRIEUX	+0.71%	+8.52%	-30.62%	-14.26%	10.42B
CARIS LIFE SCIENCES, INC.	-0.90%	+6.67%	+7.57%	-	9.04B
LANTHEUS HOLDINGS, INC.	+0.02%	-0.81%	+93.78%	+54.35%	6.51B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-2.43%	-2.47%	-30.22%	-24.83%	5.59B
DIASORIN S.P.A.	+0.33%	+2.85%	+6.23%	-8.37%	4.45B
ANDON HEALTH CO., LTD.	-2.61%	-0.71%	+58.81%	+63.00%	3.86B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.29%	+4.60%	-15.00%	-27.63%	2.86B
Average	-4.00%	+3.26%	+100.26%	+90.65%	8.63B
Weighted average by Cap.	+0.03%	+3.32%	+153.49%	+219.64%

	2014	2015
Net sales	-	-
Net income	-2.68M -2.35M -2.22M -2.02M -3.79M -257M -3.82M -26.58M -10.29M -131M -10.06M -9.84M -422M	-1.92M -1.68M -1.59M -1.45M -2.71M -184M -2.73M -19.01M -7.36M -93.83M -7.2M -7.04M -302M
Net Debt	132K 116K 110K 99.87K 187K 12.67M 188K 1.31M 508K 6.48M 497K 486K 20.81M	157K 137K 130K 118K 221K 15M 223K 1.55M 601K 7.66M 588K 575K 24.63M